Yes that to start. ENTB now has been refocused with a very gifted researcher and one that has already developed a stem cell model. This approach with Christine Ichim is far better and has a much higher probability of success than did the previous business/research model. Christine Ichim is also well connected in the research world(brother and others) and looks to be driven to succeed at this and to commercialize feline and cannine therapies. Huge opportunity.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.